These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24226811)

  • 1. The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013a).
    Rehm J; Anderson P; Gual A; Kraus L; Marmet S; Nutt DJ; Room R; Samokhvalov AV; Scafato E; Shield KD; Trapencieris M; Wiers RW; Gmel G
    Alcohol Alcohol; 2014; 49(1):118-22. PubMed ID: 24226811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining substance use disorders: do we really need more than heavy use?
    Rehm J; Marmet S; Anderson P; Gual A; Kraus L; Nutt DJ; Room R; Samokhvalov AV; Scafato E; Trapencieris M; Wiers RW; Gmel G
    Alcohol Alcohol; 2013; 48(6):633-40. PubMed ID: 23926213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction and dependence: making realities in the DSM.
    Keane H; Moore D; Fraser S
    Addiction; 2011 May; 106(5):875-7; discussion 895-7. PubMed ID: 21477232
    [No Abstract]   [Full Text] [Related]  

  • 4. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DSM-5--what has changed in therapy for and research on substance-related and addictive disorders?].
    Baumgärtner G; Soyka M
    Fortschr Neurol Psychiatr; 2013 Nov; 81(11):648-54. PubMed ID: 24194058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Craving diagnostic validity in DSM-5 Substance Use Disorders.
    Beckson M; Tucker D
    J Am Acad Psychiatry Law; 2014; 42(4):453-8. PubMed ID: 25492071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Concept Analysis of Substance Misuse to Inform Contemporary Terminology.
    Mahmoud KF; Finnell D; Savage CL; Puskar KR; Mitchell AM
    Arch Psychiatr Nurs; 2017 Dec; 31(6):532-540. PubMed ID: 29179817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescents and substance-related disorders: research agenda to guide decisions on Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).
    Crowley TJ
    Addiction; 2006 Sep; 101 Suppl 1():115-24. PubMed ID: 16930168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and remaining problems with DSM-V.
    Uchtenhagen A
    Addiction; 2011 May; 106(5):888-9; discussion 895-7. PubMed ID: 21477240
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing the dimensionality of lifetime DSM-IV alcohol use disorders and a quantity-frequency alcohol use criterion in the Australian population: a factor mixture modelling approach.
    McBride O; Teesson M; Baillie A; Slade T
    Alcohol Alcohol; 2011; 46(3):333-41. PubMed ID: 21310744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSM-5 criteria for substance use disorders: recommendations and rationale.
    Hasin DS; O'Brien CP; Auriacombe M; Borges G; Bucholz K; Budney A; Compton WM; Crowley T; Ling W; Petry NM; Schuckit M; Grant BF
    Am J Psychiatry; 2013 Aug; 170(8):834-51. PubMed ID: 23903334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept of substance use disorders. A commentary on 'Defining substance use disorders: do we really need more than heavy use' by Rehm et al.
    Saunders JB
    Alcohol Alcohol; 2013; 48(6):644-5. PubMed ID: 24097803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.
    Hasin D; Shmulewitz D; Stohl M; Greenstein E; Roncone S; Aharonovich E; Wall M
    Drug Alcohol Depend; 2020 Nov; 216():108294. PubMed ID: 33007702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social functioning and internalized stigma in individuals diagnosed with substance use disorder.
    Can G; Tanrıverdi D
    Arch Psychiatr Nurs; 2015 Dec; 29(6):441-6. PubMed ID: 26577560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Substance-related and addictive disorders in the DSM-5].
    Thomasius R; Sack PM; Strittmatter E; Kaess M
    Z Kinder Jugendpsychiatr Psychother; 2014 Mar; 42(2):115-20. PubMed ID: 24571817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why not add consumption measures to current definitions of substance use disorders? Commentary on Rehm et al.: 'Defining substance use disorders: do we really need more than heavy use?'.
    Bradley KA; Rubinsky AD
    Alcohol Alcohol; 2013; 48(6):642-3. PubMed ID: 23955834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and examination of the attribution questionnaire-substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders.
    Johnson-Kwochka A; Aalsma MC; Monahan PO; Salyers MP
    Drug Alcohol Depend; 2021 Apr; 221():108600. PubMed ID: 33689966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a research agenda for substance use disorders diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).
    Saunders JB; Schuckit MA
    Addiction; 2006 Sep; 101 Suppl 1():1-5. PubMed ID: 16930155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition.
    Kerridge BT; Saha TD; Smith S; Chou PS; Pickering RP; Huang B; Ruan JW; Pulay AJ
    Addict Behav; 2011 Sep; 36(9):912-8. PubMed ID: 21621334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic dilemmas in substance disorders.
    Brough R
    Aust Fam Physician; 2010 Aug; 39(8):536-7. PubMed ID: 20877743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.